Olympus Corporation

Olympus Corporation

Consolidated Financial Results for Fiscal 2025

May 13, 2025

Yasuo Takeuchi
Director, Representative Executive Officer, Executive Chairperson, President and Chief Executive Officer, and ESG Officer
Tatsuya Izumi
Executive Officer and Chief Financial Officer
Frank Drewalowski
Executive Officer and Gastrointestinal Solutions
Gabriela Kaynor
Executive Officer and Chief Strategy Officer
Seiji Kuramoto
Executive Officer and Surgical and Interventional Solutions
Boris Shkolnik
Executive Officer and Chief Quality Officer

PLAY LIST

from the beginning

Consolidated Financial Results for Fiscal Year 2025 and Full-Year Forecasts for Fiscal Year 2026
Disclaimer
FY2025 Consolidated Financial Results
FY2026 Consolidated Forecasts
GIS FY2026 Key Strategy
OLYSENSE: Unlocking the Full Power of Intelligent Endoscopy Ecosystem
SIS FY2026 Key Strategy
New Launch for Enhancing the Care Pathway for Urinary Stones
New Launch for Enhancing the Care Pathway for Lung Cancer
IntroductionofNewCEO
Fiscal Year 2025 Consolidated Financial Results
Fiscal Year 2025 Endoscopic Solutions Division (ESD)
Fiscal Year 2025 Therapeutic Solutions Division (TSD)
Consolidated Statement of Financial Position
Consolidated Cash Flows
FiscalYear 2026 Consolidated Forecasts
FiscalYear 2026 Forecastsby Business Segment
Shareholder Returns
@logo
Q&A
  • Q&A 1
  • Q&A 2
  • Q&A 3
  • Q&A 4
  • Q&A 5
  • Q&A 6
  • Q&A 7
  • Q&A 8
  • Q&A 9
  • Back
  • Next

Download

  • Financial results presentation materials(PDF 1.6 MB)
  • Tanshin (Financial Results)(PDF 1 MB)
  • Financial Data(PDF 285 KB)
  • Questionnaire Please answer the questionnair
  • Forward-Looking Statements
    System Requirements
GreenPower
 Link Saussure Inc.